• Publications
2 min

Akkermansia: New evidence in metabolic health

  • Publications
  • Gut Health

Our bodies are home to trillions of microbes, and scientists are still uncovering just how important many of them may be to our health.

One microbe that has attracted particular attention in recent years is Akkermansia muciniphila MucT. Naturally present in the human gut, Akkermansia has become one of the most studied microbes in metabolic health research. As evidence continues to grow, researchers are increasingly interested in understanding how this remarkable bacterium may contribute to metabolic wellbeing.

To explore this further, our experts at Danone Research & Innovation pushed the boundaries of our curiosity even further. In a recently published clinical trial, we investigated the effects of pasteurized Akkermansia muciniphila MucT in adults living with metabolic syndrome. Over a three-month period, more than 140 adults received daily supplementation, providing researchers with an opportunity to further explore Akkermansia's role in metabolic health.

The findings reinforced what earlier studies had already begun to suggest about Akkermansia's potential. Building on previous research, this study provided further evidence of the growing scientific interest in this remarkable microbe and its role in human health.

Key takeaways

  • Participants showed improvements in insulin sensitivity, helping the body respond more effectively to insulin and regulate blood sugar levels.
  • Researchers observed changes in GLP-1 response, a hormone involved in glucose control.
  • Favorable changes in body composition were also observed among study participants.
“The more we learn about Akkermansia, the more we realize there is still much to discover. Every study adds another piece to the puzzle, helping us better understand the role this remarkable microbe may play in human health.”

- Gokul Swaminathan

Director of Biotics, New Growth Spaces 

Why does this matter?

This study gives us another glimpse into what Akkermansia may be capable of. By continuing to explore how this remarkable microbe interacts with key metabolic processes, we can begin to unlock new possibilities for more personalized approaches to nutrition and health.

And with every new discovery, Akkermansia is showing us just how much more there is still to uncover.

References

  1. Akkermansia and the gut barrier: New clinical evidence. (2026, July 24). danoneresearch.com. https://www.danoneresearch.com/science-based/newsroom/press-releases/akkermansia-gut-barrier-clinical-evidence/

  2. Mount, S., Canfora, E. E., Jocken, Johan W, Umanets, A., Hul, G., Coenjaerds, M., Paula, A. L., Adriaens, Michiel E, Holst, J. J., Jardon, K. M., Segers, A., Suenaert, P., de, & Blaak, E. E. (2026). Pasteurized akkermansia muciniphila MucT for weight loss maintenance in people with overweight and obesity: A controlled randomized trial. Nature Medicine, 1–10. https://doi.org/10.1038/s41591-026-04394-7

  3. Suenaert, P., Segers, A., Rymenans, L., Devroye, H., Moll, J. M., Cani, P. D, & de Vos, W. M. (2026). Effect of pasteurized akkermansia muciniphila MucT on insulin sensitivity, body composition, and GLP-1 production in subjects with metabolic syndrome: Impact of low baseline gut akkermansia levels. Gut Microbes, 18(1), 2690689. PubMed. https://doi.org/10.1080/19490976.2026.2690689